Organ-On-Chip Market By Product (Liver-On-Chip, Heart-On-Chip, Lung-On-Chip, Kidney-On-Chip, and Others), By Application (Drug Discovery, Toxicology Research, and Others), and By End-User (Healthcare, Cosmetic Industry, and Others): Global Industry Perspective, Comprehensive Analysis, and Forecast, 2018–2025

Description

The report covers a forecast and an analysis of the organ-on-chip market on a global and regional level. The study provides historical data from 2016 to 2018 along with a forecast from 2019 to 2025 based revenue (USD Million). The study includes drivers and restraints of the organ-on-chip market along with their impact on the demand over the forecast period. Additionally, the report includes the study of opportunities available in the organ-on-chip market on a global level.

In order to give the users of this report a comprehensive view of the organ-on-chip market, we have included a competitive landscape and an analysis of Porter’s Five Forces Model for the market. The study encompasses a market attractiveness analysis, wherein all the segments are benchmarked based on their market size, growth rate, and general attractiveness.

The report provides company market share analysis to give a broader overview of the key players in the market. In addition, the report also covers key strategic developments of the market including acquisitions & mergers, new technology launch, agreements, partnerships, collaborations & joint ventures, R&D, and regional expansion of major participants involved in the market on a global and regional basis. Moreover, the study covers price trend analysis and product portfolio of various companies according to regions.

The Organ-on-chip market is fragmented based on product, application, end-user, and region. The regional segment includes North America, Europe, Latin America, Asia Pacific, and the Middle East and Africa.

Some key players of the organ-on-chip market are Emulate, AxoSim Technologies, CN Bio Innovations, Hurel Corporation, Ascendance Biotechnology, InSphero, Mimetas, Nortis, Organovo Holdings, and Tara Biosystems.

This report segments the global organ-on-chip market as follows:

Global Organ-on-chip Market: Product Analysis

• Liver-On-Chip
• Heart-On-Chip
• Lung-On-Chip
• Kidney-On-Chip
• Others

Global Organ-on-chip Market: Application Analysis

• Drug Discovery
• Toxicology Research
• Others

Global Organ-on-chip Market: End-User Analysis

• Healthcare
• Cosmetic Industry
• Others

Global Organ-on-chip Market: Regional Analysis

• North America
  • The U.S.
• Europe
  • UK
  • France
  • Germany
• Asia Pacific
  • China
  • Japan
  • India
• Latin America
  • Brazil
• Middle East and Africa

Table Of Content

• Chapter 1. Introduction
  • 1.1. Report description and scope
  • 1.2. Research scope
  • 1.3. Research methodology
    • 1.3.1. Market research process
    • 1.3.2. Market research methodology
•  
• Chapter 2. Executive Summary
  • 2.1. Global Organ-on-chip Market, 2016-2025 (USD Million)
  • 2.2. Global Organ-on-chip Market: Snapshot
•  
• Chapter 3. Organ-on-chip Market - Dynamics
  • 3.1. Introduction
  • 3.2. Market drivers
    • 3.2.1. Global Organ-on-chip market drivers: Impact analysis
    • 3.2.2. The upsurge in the use of organ-on-chip devices in the healthcare sector
    • 3.2.3. Increasing demand for organ-on-chip for drug screening
  • 3.3. Market restraints
    • 3.3.1. High costs of organ-on-chip devices
  • 3.4. Opportunities
    • 3.4.1. Increase in research activities on organ-on-chip devices
  • 3.5. Porter's Five Forces Analysis
  • 3.6. Market attractiveness analysis
    • 3.6.1. Market attractiveness analysis, by Product
    • 3.6.2. Market attractiveness analysis, by Application
    • 3.6.3. Market attractiveness analysis, by End-User
    • 3.6.4. Market attractiveness analysis, by Region
•  
• Chapter 4. Global Organ-on-chip Market - Competitive Landscape
  • 4.1. Company Market Share Analysis
    • 4.1.1. Global Organ-on-chip Market: company market share, 2018
  • 4.2. Strategic Development
    • 4.2.1. Acquisitions & Mergers
    • 4.2.2. New Launch
    • 4.2.3. Agreements, Partnerships, Collaborations and Joint Ventures
    • 4.2.4. R&D
    • 4.2.5. Regional Expansion
  • 4.3. Price Trend Analysis
  • 4.4. Product Type Portfolio
•  
• Chapter 5. Global Organ-on-chip Market - Product Segment Analysis
  • 5.1. Global Organ-on-chip market: Product overview
    • 5.1.1. Global Organ-on-chip market share, by Product, 2018 and 2025
  • 5.2. Liver-on-chip
•  
• Chapter 6. Global Liver-on-chip market, 2016-2025 (USD Million)
  • 6.1. Heart-on-chip
    • 6.1.1. Global Heart-on-chip market, 2016-2025 (USD Million)
  • 6.2. Lung-on-chip
    • 6.2.1. Global Lung-on-chip market, 2016-2025 (USD Million)
  • 6.3. Kidney-on-chip
    • 6.3.1. Global Kidney-on-chip Market, 2016-2025 (USD Million)
  • 6.4. Others
    • 6.4.1. Global Others Market, 2016-2025 (USD Million)
•  
• Chapter 7. Global Organ-on-chip Market - Application Analysis
  • 7.1. Global Organ-on-chip market: Application overview
    • 7.1.1. Global Organ-on-chip Market share, by Application, 2018 and 2025
  • 7.2. Drug Discovery
    • 7.2.1. Global Drug Discovery Market, 2016-2025 (USD Million)
  • 7.3. Toxicology Research
    • 7.3.1. Global Toxicology Research Market, 2016-2025 (USD Million)
  • 7.4. Other Applications
    • 7.4.1. Global Others Market, 2016-2025 (USD Million)
•  
• Chapter 8. Global Organ-on-chip Market - End-User Analysis
  • 8.1. Global Organ-on-chip Market: End-User overview
    • 8.1.1. Global Organ-on-chip Market share, by End-User, 2018 and 2025
  • 8.2. Healthcare
    • 8.2.1. Global Healthcare Market, 2016-2025 (USD Million)
  • 8.3. Cosmetic Industry
    • 8.3.1. Global Cosmetic Industry Market, 2016-2025 (USD Million)
  • 8.4. Others
    • 8.4.1. Global Others Market, 2016-2025 (USD Million)
•  
• Chapter 9. Global Organ-on-chip Market - Regional Analysis
  • 9.1. Global Organ-on-chip Market: Regional overview
    • 9.1.1. Global Organ-on-chip Market share, by region, 2018 and 2025
  • 9.2. North America
    • 9.2.1. North America Organ-on-chip market revenue, by Product, 2016-2025 (USD Million)
    • 9.2.2. North America Organ-on-chip market revenue, by Application, 2016-2025 (USD Million)
    • 9.2.3. North America Organ-on-chip market revenue, by End-User, 2016-2025 (USD Million)
    • 9.2.4. The U.S.
      • 9.2.4.1. The U.S. Organ-on-chip market revenue, by Product, 2016-2025 (USD Million)
      • 9.2.4.2. The U.S. Organ-on-chip market revenue, by Application, 2016-2025 (USD Million)
      • 9.2.4.3. The U.S. Organ-on-chip market revenue, by End-User, 2016-2025 (USD Million)
    • 9.2.5. Rest of North America
      • 9.2.5.1. Rest of North America Organ-on-chip market revenue, by Product, 2016-2025 (USD Million)
      • 9.2.5.2. Rest of North America Organ-on-chip market revenue, by Application, 2016-2025 (USD Million)
      • 9.2.5.3. Rest of North America Organ-on-chip market revenue, by End-User, 2016-2025 (USD Million)
  • 9.3. Europe
    • 9.3.1. Europe Organ-on-chip market revenue, by Product, 2016-2025 (USD Million)
    • 9.3.2. Europe Organ-on-chip market revenue, by Application, 2016-2025 (USD Million)
    • 9.3.3. Europe Organ-on-chip market revenue, by End-User, 2016-2025 (USD Million)
    • 9.3.4. Germany
      • 9.3.4.1. Germany Organ-on-chip market revenue, by Product, 2016-2025 (USD Million)
      • 9.3.4.2. Germany Organ-on-chip market revenue, by Application, 2016-2025 (USD Million)
      • 9.3.4.3. Germany Organ-on-chip market revenue, by End-User, 2016-2025 (USD Million)
    • 9.3.5. France
      • 9.3.5.1. France Organ-on-chip market revenue, by Product, 2016-2025 (USD Million)
      • 9.3.5.2. France Organ-on-chip market revenue, by Application, 2016-2025 (USD Million)
      • 9.3.5.3. France Organ-on-chip market revenue, by End-User, 2016-2025 (USD Million)
    • 9.3.6. UK
      • 9.3.6.1. UK Organ-on-chip market revenue, by Product, 2016-2025 (USD Million)
      • 9.3.6.2. UK Organ-on-chip market revenue, by Application, 2016-2025 (USD Million)
      • 9.3.6.3. UK Organ-on-chip market revenue, by End-User, 2016-2025 (USD Million)
    • 9.3.7. Rest of Europe
      • 9.3.7.1. Rest of Europe Organ-on-chip market revenue, by Product, 2016-2025 (USD Million)
      • 9.3.7.2. Rest of Europe Organ-on-chip market revenue, by Application, 2016-2025 (USD Million)
      • 9.3.7.3. Rest of Europe Organ-on-chip market revenue, by End-User, 2016-2025 (USD Million)
  • 9.4. Asia Pacific
    • 9.4.1. Asia Pacific Organ-on-chip market revenue, by Product, 2016-2025 (USD Million)
    • 9.4.2. Asia Pacific Organ-on-chip market revenue, by Application, 2016-2025 (USD Million)
    • 9.4.3. Asia Pacific Organ-on-chip market revenue, by End-User, 2016-2025 (USD Million)
    • 9.4.4. China
      • 9.4.4.1. China Organ-on-chip market revenue, by Product, 2016-2025 (USD Million)
      • 9.4.4.2. China Organ-on-chip market revenue, by Application, 2016-2025 (USD Million)
      • 9.4.4.3. China Organ-on-chip market revenue, by End-User, 2016-2025 (USD Million)
    • 9.4.5. Japan
      • 9.4.5.1. Japan Organ-on-chip market revenue, by Product, 2016-2025 (USD Million)
      • 9.4.5.2. Japan Organ-on-chip market revenue, by Application, 2016-2025 (USD Million)
      • 9.4.5.3. Japan Organ-on-chip market revenue, by End-User, 2016-2025 (USD Million)
    • 9.4.6. India
      • 9.4.6.1. India Organ-on-chip market revenue, by Product, 2016-2025 (USD Million)
      • 9.4.6.2. India Organ-on-chip market revenue, by Application, 2016-2025 (USD Million)
      • 9.4.6.3. India Organ-on-chip market revenue, by End-User, 2016-2025 (USD Million)
    • 9.4.7. Rest of Asia Pacific
      • 9.4.7.1. Rest of Asia Pacific Organ-on-chip market revenue, by Product, 2016-2025 (USD Million)
      • 9.4.7.2. Rest of Asia Pacific Organ-on-chip market revenue, by Application, 2016-2025 (USD Million)
      • 9.4.7.3. Rest of Asia Pacific Organ-on-chip market revenue, by End-User, 2016-2025 (USD Million)
  • 9.5. Latin America
    • 9.5.1. Latin America Organ-on-chip market revenue, by Product, 2016-2025 (USD Million)
    • 9.5.2. Latin America Organ-on-chip market revenue, by Application, 2016-2025 (USD Million)
    • 9.5.3. Latin America Organ-on-chip market revenue, by End-User, 2016-2025 (USD Million)
    • 9.5.4. Brazil
      • 9.5.4.1. Brazil Organ-on-chip market revenue, by Product, 2016-2025 (USD Million)
      • 9.5.4.2. Brazil Organ-on-chip market revenue, by Application, 2016-2025 (USD Million)
      • 9.5.4.3. Brazil Organ-on-chip market revenue, by End-User, 2016-2025 (USD Million)
    • 9.5.5. Rest of Latin America
      • 9.5.5.1. Rest of Latin America Organ-on-chip market revenue, by Product, 2016-2025 (USD Million)
      • 9.5.5.2. Rest of Latin America Organ-on-chip market revenue, by Application, 2016-2025 (USD Million)
      • 9.5.5.3. Rest of Latin America Organ-on-chip market revenue, by End-User, 2016-2025 (USD Million)
  • 9.6. The Middle East and Africa
    • 9.6.1. The Middle East and Africa Organ-on-chip market revenue, by Product, 2016-2025 (USD Million)
    • 9.6.2. The Middle East and Africa Organ-on-chip market revenue, by Application, 2016-2025 (USD Million)
    • 9.6.3. The Middle East and Africa Organ-on-chip market revenue, by End-User, 2016-2025 (USD Million)
•  
• Chapter 10. Company Profile
  • 10.1. Emulate
    • 10.1.1. Overview
    • 10.1.2. Financials
    • 10.1.3. Product portfolio
    • 10.1.4. Business strategy
    • 10.1.5. Recent developments
  • 10.2. AxoSim Technologies
    • 10.2.1. Overview
    • 10.2.2. Financials
    • 10.2.3. Product portfolio
    • 10.2.4. Business strategy
    • 10.2.5. Recent developments
  • 10.3. CN Bio Innovations
    • 10.3.1. Overview
    • 10.3.2. Financials
    • 10.3.3. Product portfolio
    • 10.3.4. Business strategy
    • 10.3.5. Recent developments
  • 10.4. Hurel Corporation
    • 10.4.1. Overview
    • 10.4.2. Financials
    • 10.4.3. Product portfolio
    • 10.4.4. Business strategy
    • 10.4.5. Recent developments
  • 10.5. Ascendance Biotechnology, Inc.
  • 10.6. InSphero
    • 10.6.1. Overview
    • 10.6.2. Financials
    • 10.6.3. Product portfolio
    • 10.6.4. Business strategy
    • 10.6.5. Recent developments
  • 10.7. Mimetas
    • 10.7.1. Overview
    • 10.7.2. Financials
    • 10.7.3. Product portfolio
    • 10.7.4. Business strategy
    • 10.7.5. Recent developments
  • 10.8. Nortis
    • 10.8.1. Overview
    • 10.8.2. Financials
    • 10.8.3. Product portfolio
    • 10.8.4. Business strategy
    • 10.8.5. Recent developments
  • 10.9. Organovo Holdings
    • 10.9.1. Overview
    • 10.9.2. Financials
    • 10.9.3. Product portfolio
    • 10.9.4. Business strategy
    • 10.9.5. Recent developments
  • 10.10. Tara Biosystems
    • 10.10.1. Overview
    • 10.10.2. Financials
    • 10.10.3. Product portfolio
    • 10.10.4. Business strategy
    • 10.10.5. Recent developments

Methodology

Free Analysis

Organ-on-chip is a 3D microfluidic cell structure chip that simulates a particular organ in the body along with its mechanics and physiological reactions using the computer chip manufacturing method, to execute procedures like breathing, peristalsis, and curing infections. The organ-on-chip plays an important role in the fields of drug discovery and research, as it assists in achieving greater precision in toxicity identification and testing to decrease the chances of drug failure in human clinical trials. In addition, traditional animal models were not guaranteed to correctly imitate human pathophysiology. The organ chip consists of a flexible polymer of the size of the computer memory stick, which has hollow microfluid channels for the cells of a particular human organ that is surrounded by the organ-specific physical microenvironment.

The increasing issues related to one’s health and rising demand for organ culture instruments based on lung and kidney are driving the organ-on-chip market worldwide. In addition, increasing projects by prominent chip organ implementation organizations will further contribute to the organ-on-chip market globally. For example, in 2017, the Netherlands Scientific Research Organization (NWO) discussed its plans for the country’s organ-on-chip initiative that focused on advances and growth of the same. However, the imitation of the extremely complicated architecture of human organs may limit the organ-on-chip market over the forecast time period. The Asia Pacific region's flourishing healthcare sector and China's elevated median age, which is one of Asia Pacific's most important markets, will further fuel the development of the worldwide organ-on-chip market in the years ahead.

The organ-on-chip market is fragmented based on product, application, and end-user. Based on product, the organ-on-chip market is classified into kidney-on-chip, lung-on-chip, heart-on-chip, liver-on-chip, and others. The application segment of the organ-on-chip market includes toxicology research, drug discovery, and others. The drug discovery segment is anticipated to dominate the organ-on-chip market in the years ahead. The end-user segment is divided into cosmetic industry, healthcare, and others. The healthcare sector will hold a major share of the market for organ-on-chip globally in the future.

North America will hold a major share of the organ-on-chip market globally, owing to rapid technological advances in the region. The Asia Pacific organ-on-chip market will witness a substantial growth rate in the organ-on-chip market over the forecast time period, due to the region's elevated population base and the flourishing healthcare industry.

Some key players of the organ-on-chip market are Emulate, AxoSim Technologies, CN Bio Innovations, Hurel Corporation, Ascendance Biotechnology, InSphero, Mimetas, Nortis, Organovo Holdings, and Tara Biosystems.